CLINICAL_TRIALS
trial_result
· 2013-01-09
Clinical Trial Update: Treatment With Pazopanib for Neoadjuvant Breast Cancer [Phase 2]
Summary
Phase 2 trial results for pazopanib as neoadjuvant treatment in breast cancer have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Breast | Phase 2 | Status: COMPLETED | Results posted: 2013-01-09